Advertisement

Topics

GW Pharmaceuticals Announces the Closing of Public Offering of ADSs

12:42 EDT 5 Oct 2018 | Investing News Network

GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, announced today the closing of the previously announced underwritten public offering on the Nasdaq Global Market by GW of 1,900,000 American Depositary Shares and the full exercise by the underwriters of their option to purchase … Continued

The post GW Pharmaceuticals Announces the Closing of Public Offering of ADSs appeared first on Investing News Network.

Original Article: GW Pharmaceuticals Announces the Closing of Public Offering of ADSs

NEXT ARTICLE

More From BioPortfolio on "GW Pharmaceuticals Announces the Closing of Public Offering of ADSs"

Advertisement
Quick Search
Advertisement
Advertisement